IGF-1 LR3

GH Axis Inventory

The GH Axis Inventory is the primary performance multiplier inside the peptide model. Growth hormone signaling influences body composition, tissue repair, recovery bandwidth, and metabolic responsiveness. Without this axis, fat loss becomes muscle loss, recovery slows, and training output plateaus. This inventory is intentionally layered to provide flexibility across intensity levels: Sermorelin serves as entry-level endogenous stimulation. Tesamorelin (10mg & 20mg) targets visceral fat and provides scalable leverage. Tesamorelin / Ipamorelin blends amplify GH pulses for structured recomposition. Tesamorelin / CJC / Ipamorelin creates triple-pathway synergy. CJC-1295 (DAC & No DAC) allows duration control — pulse vs sustained. Ipamorelin provides clean adjunct stimulation. IGF-1 LR3 delivers downstream growth expression. Fragment 176-191 targets fat mobilization pathways. This layered approach prevents over-reliance on a single compound and allows protocols to adapt to client progression. As volume increases, GH flexibility becomes revenue protection — because it prevents stagnation. Strategically, the GH axis: Enhances recomposition efficiency Preserves lean mass during fat loss Accelerates recovery Supports connective tissue repair Increases training capacity At scale, GH inventory becomes a central profit driver. It supports both base stacks and premium builds. It is not optional — it is structural. This is not a single product category. It is a signaling architecture built to scale results.

Weight Loss

This is not a “fat burner stack.” It is a layered metabolic architecture designed to systematically control intake, improve nutrient partitioning, increase mitochondrial output, mobilize stored fat, and preserve lean mass — in that order. 1️⃣ Foundation: Insulin & Appetite Control Retatrutide anchors the system. By targeting GLP-1, GIP, and glucagon pathways simultaneously, it reduces appetite, improves glucose handling, and increases energy expenditure. If insulin is unstable, nothing downstream works efficiently. This layer reduces fat-storage signaling and improves nutrient partitioning so calories are directed toward muscle instead of adipose tissue. 2️⃣ Mitochondrial Output Layer The Mito Blend (SS-31, MOTS-c, 5-Amino-1MQ), combined with SLU-PP-332 and BAM15, upgrades cellular energy mechanics. SS-31 improves mitochondrial membrane efficiency. MOTS-c enhances glucose utilization and metabolic flexibility. 5-Amino-1MQ supports NAD+ preservation and metabolic turnover. SLU-PP-332 activates PGC-1α to mimic endurance training at the cellular level. BAM15 increases calorie burn through controlled mitochondrial uncoupling. This layer ensures liberated fat is oxidized instead of recycled. It increases baseline metabolic throughput without relying on stimulants. 3️⃣ Growth Hormone Axis Optimization Tesamorelin or CJC-1295/Ipamorelin restores physiologic GH pulsatility. Proper GH signaling preferentially targets visceral fat while supporting sleep quality, connective tissue repair, and lean mass preservation. This is not replacement therapy — it is rhythm restoration. The GH layer enhances lipolysis and improves recovery so training output can increase without overtraining. 4️⃣ Direct Lipolytic Signaling HGH Frag 176-191 and AOD-9604 act downstream of GH, signaling adipose tissue to release stored fat. These compounds do not meaningfully elevate systemic IGF-1, making them targeted fat-mobilization tools rather than full hormonal modifiers. This layer increases the rate of fat release, especially when paired with fasted cardio or Zone 2 work. 5️⃣ Structural Fat Reduction (Advanced) Adipotide is reserved for aggressive protocols. It targets adipose vasculature and signals structural fat-mass reduction. This is cycle-based and monitored carefully, used when cosmetic or visceral fat is stubborn. 6️⃣ Muscle Preservation & Anabolic Signaling IGF-1 LR3 is layered during caloric deficit to protect lean tissue. When calories drop and fat loss accelerates, muscle loss risk increases. IGF-1 LR3 provides anabolic signaling to preserve training output and structural mass. 7️⃣ Behavioral Compliance Layer MT2 acts as secondary appetite suppression and behavioral support. It is not foundational but improves adherence during aggressive phases. System Logic This stack works because it addresses every bottleneck: Appetite & insulin control Mitochondrial inefficiency GH rhythm decline Fat mobilization rate Muscle preservation Compliance under deficit Each layer solves a specific constraint. When deployed sequentially rather than simultaneously, the system creates compound leverage. Strategic Outcome When structured correctly, this architecture: Reduces visceral and subcutaneous fat Preserves or improves lean mass Enhances recovery and sleep Increases metabolic flexibility Maintains endocrine integrity It is aggressive but organized. Not chaotic, not redundant, not stimulant-driven. The result is controlled, measurable recomposition — not just weight loss.

Lean Muscle

The intermediate stack builds on GH optimization by adding direct anabolic signaling through IGF-1 LR3 and improving recovery capacity with BPC-157. This layer enhances nutrient partitioning—more calories go toward muscle, not fat—while increasing training capacity and reducing injury risk. The result is faster, more noticeable lean muscle growth with improved resilience.

Lean Muscle

The advanced lean muscle stack integrates mitochondrial optimization with anabolic signaling, creating a high-performance growth environment. MOTS-c and SS-31 improve energy production and endurance, allowing for greater training output, while GH and IGF pathways drive hypertrophy and recovery. This results in denser muscle, better conditioning, and sustained performance without excessive fatigue or burnout.

Lean Muscle

This next-level lean muscle stack is a full-spectrum performance system designed to optimize growth, recovery, hormone signaling, and metabolic efficiency simultaneously. The dual GH-axis approach—AM and PM pulses using Tesamorelin, Ipamorelin, and CJC-1295—maximizes growth hormone output and recovery cycles. IGF-1 LR3 drives direct hypertrophy and muscle cell proliferation, while Retatrutide improves nutrient partitioning and metabolic control to keep gains lean. DSIP enhances sleep quality, which is where the majority of recovery and GH release occurs, and Kisspeptin supports upstream hormonal signaling for optimal endocrine balance. Melanotan II adds a subtle edge through melanocortin pathway activation, improving recovery, mood, and work capacity. The result is a high-output system that builds dense, lean muscle while staying metabolically tight and hormonally optimized.